Request Deal Involvement
Medtronic to spin-off its diabetes business for $8bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Goldman Sachs
legal advisors
Cleary Gottlieb Steen & Hamilton
legal advisors
Baker McKenzie
legal advisors to financial advisors
Davis Polk & Wardwell
legal advisors
Skadden Arps Slate Meagher & Flom
or
Principals
target
MEDTRONIC (DIABETES BUSINESS)
vendor
MEDTRONIC PLC
bidder
INSTITUTIONAL INVESTORS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite